Advances in Cancer Detection, Prediction, and Prognosis Using Artificial Intelligence and Machine Learning
Langue : anglais
Edité par Springer, 2025
- Livre relié
- Neuf

Vendeur : Home-set, Mannheim, AllemagneHome-set
Vendeur AbeBooks depuis 13 avril 2026
Etat: Neuf
EUR 267,49
Quantité disponible : 2 disponibles
Ajouter au panierA propos de cet article
This book covers all aspects of computational biology in studying cancer diagnosis and prognosis, including newer applications involving infection and inflammation, as well as basic information on advanced simulation techniques. It describes the different tools, risk-based modeling techniques, early prediction algorithms and the biomarkers of different cancers that help in their early and better diagnosis in routine clinical practice involving multiple organs and systems.Early cancer diagnosis and artificial intelligence (AI) are rapidly evolving fields, with the UK's National Health Service aiming to improve early diagnosis rates to 75% by 2028. Screening can improve early cancer detection and mortality, but patient selection and risk stratification are key challenges. AI algorithms can facilitate cancer diagnosis by triggering investigation in screened individuals according to clinical parameters and automating clinical workflows where capacity is limited. Machine learning, which learns complex data patterns to make predictions has the potential to revolutionize early cancer diagnosis and support capacity concerns through automation.The chapters present the advances in diagnosing different types of cancer including bladder cancer, breast cancer, colorectal cancer, kidney (renal cell) cancer, lung cancer, lymphoma, pancreatic cancer, prostate cancer, skin cancer, uterine and metastatic cancers. The chapters also cover recurrent cancer, advanced cancer treatment, and the management of cancer in adolescents and young adults. The pan-cancer analyses presented in the book cover all aspects of early diagnosis, supplemented by numerous illustrations and figures to offer a fresh perspective and lucid understanding of computer-based approaches in cancer management.This book simplifies computational methods in medical diagnosis and highlights the benefits of early detection compared to other methods. It is targeted at biomedical scientists and clinical practitioners who conduct artificial intelligence-based research. Sprache: Englisch Gewicht in Gramm: 884.…
N° de réf. du vendeur IB-4447351
- Titre
- Advances in Cancer Detection, Prediction, and Prognosis Using Artificial Intelligence and Machine Learning
- Éditeur
- Springer
- Année de publication
- 2025
- État de l'article
- Neu
- Reliure
- Gebundene Ausgabe
- Langue
- anglais
- ISBN à 10 chiffres
- 9819693454
- ISBN à 13 chiffres
- 9789819693450
- Poids de l'article
- 884 grammes
This book covers all aspects of computational biology in studying cancer diagnosis and prognosis, including newer applications involving infection and inflammation, as well as basic information on advanced simulation techniques. It describes the different tools, risk-based modeling techniques, early prediction algorithms and the biomarkers of different cancers that help in their early and better diagnosis in routine clinical practice involving multiple organs and systems.
Early cancer diagnosis and artificial intelligence (AI) are rapidly evolving fields, with the UK's National Health Service aiming to improve early diagnosis rates to 75% by 2028. Screening can improve early cancer detection and mortality, but patient selection and risk stratification are key challenges. AI algorithms can facilitate cancer diagnosis by triggering investigation in screened individuals according to clinical parameters and automating clinical workflows where capacity is limited. Machine learning, which learns complex data patterns to make predictions has the potential to revolutionize early cancer diagnosis and support capacity concerns through automation.
The chapters present the advances in diagnosing different types of cancer including bladder cancer, breast cancer, colorectal cancer, kidney (renal cell) cancer, lung cancer, lymphoma, pancreatic cancer, prostate cancer, skin cancer, uterine and metastatic cancers. The chapters also cover recurrent cancer, advanced cancer treatment, and the management of cancer in adolescents and young adults. The pan-cancer analyses presented in the book cover all aspects of early diagnosis, supplemented by numerous illustrations and figures to offer a fresh perspective and lucid understanding of computer-based approaches in cancer management.
This book simplifies computational methods in medical diagnosis and highlights the benefits of early detection compared to other methods. It is targeted at biomedical scientists and clinical practitioners who conduct artificial intelligence-based research.
« Synopsis » peut appartenir à une autre édition de cet ouvrage.
À propos de l’auteur
Dr. Rajeev Nema is currently working as an assistant professor at Manipal University in Jaipur, Rajasthan. He has more than 9 years of post-doctoral experience focused on diverse molecular cancer biology studies. Barkatullah University's Life Science Department awarded him a Ph.D. He used natural product chemistry in his thesis study to define the key chemical activities of three distinct cancer cell lines: A549 (lung cancer), MCF-7 (breast cancer), and PA-1 (pancreatic cancer). He worked as a Research Associate at the All-India Institute of Medical Science (AIIMS) in Bhopal in the Department of Biochemistry to investigate the "crosstalk between ROR1/2 and S1P signaling" pathways and how these pathways regulate cell growth, apoptosis, and invasion in lung cancer cells. Following that he worked as a Senior Research Scientist in the Department of Gene Expression (Oncology Development) at 3B BlackBio Biotech India Ltd., 7-C, Industrial Area, Govindpura, Bhopal, 462023, (M.P.) India. In addition, from February to August 2023, he worked as a postdoctoral researcher in the Department of Oncological Sciences at Mount Sinai's Icahn School of Medicine.
Dr. Ashok Kumar is currently working as an Professor in the Department of Biochemistry of All India Institute of Medical Sciences Bhopal. His current research interest is understanding the role of non-coding RNAs and sphingosine-1-phosphate signaling in Head and Neck Cancer. He received his PhD degree from Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) Lucknow, India. Then, he received postdoctoral training from UCSF-Benioff’s Children’s Hospital Oakland & Research Centre, Oakland, CA, USA. Dr. Ashok Kumar’s major area of research work is Cell & Molecular Biology, Cancer Biology, Immunology & Sphingolipid signaling. He has more than 15 years of research experience. He has published more than 50 research articles and 10 book chapters, and he has edited two books. He is a member of several international professional societies including American Association of Cancer Research and Fellow of Royal Society of Biology.
Prof. Dinesh Kumar Saini is currently working as a professor in the department of computer and communication engineering at the School of Computers and IT at Manipal University Jaipur, Jaipur, India. His current research interests are computer science and engineering, information technology, health science and AI, software systems, business administration, and human resource management. He received his PhD degree from Birla Institute of Technology and Science, Pilani, Rajasthan, India. While serving as Dean of the Faculty of Computing and Information Technology in Oman, he maintained a strong academic record. He has administrative experience as a university senator, university research council member, university library committee member, faculty research coordinator, etc. He has conceived, planned, developed, organized, and implemented numerous seminars, conferences, MDPs, EDPs, and FDPs. He has published more than 140 research articles and 10 book chapters, as well as edited two books. He is a member of several international professional societies, including FIMA, FRSS, FIANG, MIEEE, MACM, and MCSI.
« A propos de ce titre » peut appartenir à une autre édition de cet ouvrage.
Home-set
Mannheim, Allemagne
Vendeur AbeBooks depuis 13 avril 2026
Frais d'expédition de Allemagne vers Etats-Unis
| Article | 10 à 12 jours ouvrés | 8 à 10 jours ouvrés |
|---|---|---|
| Premier article | EUR 49,90 | EUR 75,00 |
Modes de paiement
- Chèque
Spécialité
BuchProfil professionnel du vendeur
Home-set
Allemagne
Droit de rétractation
Si vous êtes un consommateur, vous pouvez exercer votre droit de rétractation sur le contrat conformément à ce qui suit. Le mot « consommateur » désigne toute personne physique agissant à des fins qui n'entrent pas dans le cadre de son activité commerciale, artisanale ou professionnelle.
Informations concernant le droit de rétractation
Droit statutaire de rétractation
Vous avez le droit d'exercer votre droit de rétractation sur ce contrat dans les 14 jours sans donner de raison.
Le délai de rétractation expirera au bout de 14 jours à compter du jour où vous-même, ou un tiers autre que le transporteur et désigné par vous, prendrez physiquement possession de la dernière marchandise, du dernier lot ou de la dernière pièce.
Pour exercer votre droit de rétractation, remplissez électroniquement et envoyez une déclaration claire sur notre site Web, sous « Vos achats » dans « Votre compte ». Nous vous communiquerons sans délai un accusé de réception de cette rétractation sur un support durable (par exemple, par e-mail).
Pour respecter le délai de rétractation, il vous suffit d'envoyer votre message concernant l'exercice de votre droit de rétractation avant l'expiration du délai de rétractation.
Effets de la rétractation
Si vous exercez votre droit de rétractation sur ce contrat, nous vous rembourserons tous les paiements que vous avez effectués, y compris les frais de livraison (à l'exception des frais supplémentaires résultant du choix d'un mode de livraison autre que le type de livraison standard le moins cher que nous proposons).
Nous pouvons déduire du remboursement la perte de valeur de toute marchandise livrée, si la perte est le résultat d'une manipulation inutile de votre part.
Nous effectuerons le remboursement dans les meilleurs délais, et au plus tard 14 jours après le jour où nous aurons été informés de votre décision d'exercer votre droit de rétractation sur ce contrat.
Nous effectuerons le remboursement en utilisant le même moyen de paiement que celui que vous avez utilisé pour la transaction initiale, sauf si vous en avez expressément convenu autrement ; en tout état de cause, aucuns frais ne vous seront facturés à la suite d'un tel remboursement.
Nous pouvons suspendre le remboursement jusqu'à ce que nous ayons reçu les marchandises ou que vous ayez fourni la preuve que vous avez renvoyé les marchandises, en fonction de la première éventualité.
Vous devez renvoyer les marchandises ou les remettre à Home-set, Mannheim, Germany, sans retard injustifié et, en tout état de cause, au plus tard 14 jours à compter du jour où vous nous avez communiqué votre décision de rétractation du présent contrat. Le délai est respecté si vous renvoyez les marchandises avant l'expiration du délai de 14 jours. Vous devrez prendre en charge les frais directs du renvoi des marchandises. Vous n'êtes responsable que de toute diminution de valeur des marchandises résultant d'une manipulation autre que celle nécessaire pour établir la nature, les caractéristiques et le fonctionnement des marchandises.
Exceptions au droit de rétractation
Le droit de rétractation ne s'applique pas à ce qui suit :
- Distribution de journaux, de revues ou de magazines, à l'exception des contrats d'abonnement ; et
- Fourniture d'un contenu numérique qui n'est pas fourni sur un support matériel (par exemple, sur un CD ou un DVD) si vous avez accepté, lors de votre commande, que nous puissions commencer à le livrer et que vous ne puissiez pas exercer votre droit de rétractation une fois la livraison commencée.